MENU
+Compare
LENZ
Stock ticker: NASDAQ
AS OF
May 2 closing price
Price
$29.52
Change
+$0.64 (+2.22%)
Capitalization
813.11M

LENZ LENZ Therapeutics Forecast, Technical & Fundamental Analysis

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LENZ with price predictions
May 02, 2025

LENZ in upward trend: 10-day moving average broke above 50-day moving average on April 24, 2025

The 10-day moving average for LENZ crossed bullishly above the 50-day moving average on April 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on LENZ as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LENZ just turned positive on April 16, 2025. Looking at past instances where LENZ's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

LENZ moved above its 50-day moving average on April 17, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LENZ advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

LENZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 133 cases where LENZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LENZ moved out of overbought territory on April 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LENZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LENZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.897) is normal, around the industry mean (14.232). P/E Ratio (0.000) is within average values for comparable stocks, (64.218). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.855). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.894).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LENZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LENZ is expected to report earnings to rise 97.83% to -91 cents per share on March 25

LENZ Therapeutics LENZ Stock Earnings Reports
Q4'23
Est.
$-0.91
Q4'24
Missed
by $0.36
Q3'23
Est.
$-0.24
Q2'23
Missed
by $5.82
Q1'23
Missed
by $2.61
The last earnings report on March 19 showed earnings per share of -46 cents, missing the estimate of -10 cents. With 267.06K shares outstanding, the current market capitalization sits at 813.11M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFREX40.910.50
+1.24%
DFA Real Estate Securities I
ARYEX26.31N/A
N/A
American Century Real Estate Y
SJGAX28.71N/A
N/A
Steward Large Cap Growth A
LIMAX6.43N/A
N/A
Cromwell Tran Sustainable Focus Investor
CLVRX31.52N/A
N/A
Calvert US Large Cap Value Rspnb Idx R6

LENZ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+2.22%
KYMR - LENZ
47%
Loosely correlated
+2.11%
ETNB - LENZ
44%
Loosely correlated
+7.38%
ZYME - LENZ
43%
Loosely correlated
+0.62%
ERAS - LENZ
43%
Loosely correlated
+6.04%
ELVN - LENZ
42%
Loosely correlated
+3.32%
More